{"entity":{"type":"insider","cik":"0001735050","url":"/insider/0001735050","json_url":"/insider/0001735050.json","name":"Stagg Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2018-04-26","last":"2018-10-11","span_basis":"filed_date"},"name_variants":[{"name":"Stagg Robert","source":"filing","n_filings":3,"first_seen":"2018-04-26","last_seen":"2018-10-11"}],"transactions":[{"id":6427986,"accession":"0001567619-18-004058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-004058","line_url":"/filing/0001567619-18-004058#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001735050","owner_name":"Stagg Robert","owner_url":"/insider/0001735050","role":"Officer (SVP, Clinical R&D)","officer_title":"SVP, Clinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":927.0,"shares_display":"927","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":1863.27,"total_display":"1,863.27","shares_owned_after":40670.0,"shares_owned_after_display":"40,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-10","filed_date":"2018-10-11","scope":"insider"},{"id":6798108,"accession":"0001567619-18-003957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-003957","line_url":"/filing/0001567619-18-003957#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001735050","owner_name":"Stagg Robert","owner_url":"/insider/0001735050","role":"Officer (SVP, Clinical R&D)","officer_title":"SVP, Clinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1686.0,"shares_display":"1,686","price_per_share":2.1289,"price_display":"2.13","price_state":"stated","total_value":3589.3254,"total_display":"3,589.33","shares_owned_after":41597.0,"shares_owned_after_display":"41,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-09","filed_date":"2018-10-10","scope":"insider"},{"id":6874644,"accession":"0001140361-18-019834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-019834","line_url":"/filing/0001140361-18-019834#line-1","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001735050","owner_name":"Stagg Robert","owner_url":"/insider/0001735050","role":"Officer (SVP, Clinical R&D)","officer_title":"SVP, Clinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4051.0,"shares_display":"4,051","price_per_share":2.6779,"price_display":"2.68","price_state":"stated","total_value":10848.1729,"total_display":"10,848.17","shares_owned_after":43283.0,"shares_owned_after_display":"43,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-24","filed_date":"2018-04-26","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Officer (SVP, Clinical R&D)","n_filings":3,"first_seen":"2018-04-26","last_seen":"2018-10-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001735050","retrieved_at":"2026-08-21T14:51:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}